Dishonesty in medical research and publication and the remedial measures

Annals of Cardiac Anaesthesia

Volumn 21, Issue 2, 2018, Pages 111-113

  Neema, Praveen Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; FRAMINGHAM RISK SCORE; HUMAN; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PUBLICATION; SCIENTIFIC LITERATURE; TEACHING; PUBLISHING; SCIENTIFIC MISCONDUCT; STANDARDS; TRENDS;

BIOMEDICAL RESEARCH; JOURNALISM, MEDICAL; PERIODICALS AS TOPIC; PUBLISHING; SCIENTIFIC MISCONDUCT;

EID: 85045635983     PISSN: 09719784     EISSN: 09745181     Source Type: Journal    
DOI: 10.4103/aca.ACA_58_18     Document Type: Editorial

References (31)

1. Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, Van Raemdonck D, et al. Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg 2009;35:13-20.
2. Kato Y, Matsumoto I, Tomita S, Watanabe G. A novel technique to prevent intra-operative pneumothorax in awake coronary artery bypass grafting: Biomaterial neo-pleura. Eur J Cardiothorac Surg 2009;35:37-41.
3. Kirsch ME, Ooka T, Zannis K, Deux JF, Loisance DY. Bioprosthetic replacement of the ascending thoracic aorta: What are the options? Eur J Cardiothorac Surg 2009;35:77-82.
4. Chachques JC. Cardiomyoplasty: Is it still a viable option in patients with end-stage heart failure? Eur J Cardiothorac Surg 2009;35:201-3.
5. Treasure T. Are randomised trials needed in the era of rapidly evolving technologies? Eur J Cardiothorac Surg 2009;35:474-8.
6. Vecht JA, Athanasiou T, Ashrafian H, Mayer E, Darzi A, von Segesser LK, et al. Surgeons produce innovative ideas which are frequently lost in the labyrinth of patents. Eur J Cardiothorac Surg 2009;35:480-8.
7. Robicsek F. When four plus four is less than eight: The nuss operation. Eur J Cardiothorac Surg 2009;35:559-60.
8. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham heart study and the epidemiology of cardiovascular disease: A historical perspective. Lancet 2014;383:999-1008.
9. Neema PK. Medical research: Is everything all right? J Anaesthesiol Clin Pharmacol 2011;27:159-61.
10. Bhargava S. Committee Recommendations for Work Standards for Faculty of Autonomous Institutions. Ministry of Health and Family Welfare, GOI, OM; 2012.
11. Medical Council of India. Circular No. MCI-12(1)/2015-TEQ/131880. Available from: http://www.mciindia.org/circulars/Circular-03.09.2015-TEQ-Promotion-Publication.pdf. [Last accessed on 2018 Mar 31].
12. Medical Council of India. Minimum Qualifications for Teachers in Medical Institutions Regulations; 1998. Available from: http://www.mciindia.org/Rules-and-Regulation/TEQ-REGULATIONS-16.05.15.pdf. [Last accessed on 2018 Mar 31].
13. Dennis N. A New Record for Retractions? Science Insider. American Association for the Advancement of Science; 5 July, 2012.
14. Adam M. Japanese PONV Researcher Probed in Sweeping Research Fraud Case. Anesthesiology News; 7 March, 2012.
15. Fujii Y. Japanese Anaesthetist and Record Breaking Research Fraud. Available from: https://www.drgeoffnutrition.wordpress.com/.../yoshitaka-fujii-japanese-anaesthetist-and-rec. [Last accessed on 2018 Mar 31].
16. Lock S. Misconduct in medical research: Does it exist in Britain? BMJ 1988;297:1531-5.
17. Lock S, Wells F, editors. Research Misconduct: A resume of recent events. In: Fraud and Misconduct in Medical Research. 2nd ed. London: BMJ Publishing Group; 1996. p. 14-39.
18. Fang FC, Steen RG, Casadevall A. Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci U S A 2012;109:17028-33.
19. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003;326:1167-70.
20. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71.
21. Hawkes N. GlaxoSmithKline pays $3bn to settle dispute over rosiglitazone and other drugs. BMJ 2011;343:d7234.
22. GlaxoSmithKline to Pay $3bn in US Drug Fraud Scandal. Available from: http://www.bbc.co.uk/news/world-us-canada-18673220. [Last accessed on 2018 Mar 31].
23. Fitzpatrick M. MMR: Risk, choice, chance. Br Med Bull 2004;69:143-53.
24. Deer B. How the case against the MMR vaccine was fixed. BMJ 2011;342:c5347.
25. Ravnskov U, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: A systematic review. BMJ Open 2016;6:e010401.
26. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011;CD004816.
27. Final Recommendation Statement: Statin Use for the Primary. Available from: https://www.uspreventiveservicestaskforce.org/.../RecommendationStatementFinal/stati. [Last accessed on 2018 Mar 03].
28. Wilmshurst P. Dishonesty in medical research. Med Leg J 2007;75:3-12.
29. Farthing M. Keep It Real. Available from: http://www.time shighereducation.co.uk/420565. [Last accessed on 2018 Mar 31].
30. Kleinert S; Committee on Publication Ethics (COPE). COPE's retraction guidelines. Lancet 2009;374:1876-7.
31. Cressey D. British Science Needs Integrity Overhaul. Available from: http://www.nature.com/news/britishscience-needs-integrity-overhaul-1.9803. [Last accessed on 2018 Mar 31].